Objective-One potential mechanism through which obesity exerts adverse effects on the vascular system is by increasing aortic stiffness, a change known to be predictive of increased cardiovascular mortality. The aim of this study was to investigate the pathophysiology that links obesity to aortic stiffening. Approach and Results-Obese (ob/ob) mice were used to examine physical, morphological, and molecular changes in the aorta in response to obesity. ob/ob mice had increased aortic pulse wave velocity and tissue rigidity. ob/ob aorta exhibited decreases of lysyl oxidase (LOX) activity and cross-linked elastin, and increases of elastin fragmentation and elastolytic activity. The aortas of ob/ob mice were surrounded by a significant amount of proinflammatory and pro-oxidative perivascular adipose tissue. In vitro studies revealed that the conditioned medium from differentiated adipocytes or the perivascular adipose tissue of ob/ob mice attenuated LOX activity. Furthermore, inhibition of LOX in wild-type lean mice caused elastin fragmentation and induced a significant increase in pulse wave velocity. Finally, we found that obese humans had stiffer arteries and lower serum LOX levels than do normal-weight humans. Conclusion-Our results demonstrated that obesity resulted in aortic stiffening in both humans and mice, and established a causal relationship between LOX downregulation and aortic stiffening in obesity. 
O besity increases the risk for stroke, incident cardiovascular diseases, cardiovascular mortality, and all-cause mortality in humans. One potential mechanism by which obesity increases cardiovascular risk is its effect of increasing aortic stiffness, a change known to be associated with other subclinical vascular diseases and predictive of increased cardiovascular mortality. 1 Thus, excess body fat, abdominal visceral fat, and a large waist circumference have been identified as risk factors for accelerated arterial stiffening in the general population from the young to the elderly. [1] [2] [3] The passive biomechanical properties that contribute to vascular stiffness are largely determined by extracellular matrix proteins, including elastin and collagen. Elastin provides vascular elasticity and wall compliance, whereas collagen contributes to wall strength and stiffness. Abnormalities in the quantity and quality of both elastin and collagen contribute to aortic stiffening. 4, 5 Furthermore, extracellular matrix stability is assured by the intra-and intermolecular covalent cross-linking of elastin and collagen, initiated by lysyl oxidase (LOX), a copper-dependent amine oxidase. In the vascular wall, LOX is expressed in fibroblasts, endothelial cells, and vascular smooth muscle cells. 6 LOX is synthesized as a preproLOX that undergoes post-translational modifications to yield the proenzyme proLOX, which is proteolytically processed by bone morphogenetic protein-1 and other proteinases to release the active enzyme LOX. LOX deficiency in mice leads to aortic aneurysms, tortuosity, and rupture. 7, 8 Thus, the amount and activity of LOX are essential to maintain the tensile and elastic features of blood vessels.
Most blood vessels in the body are surrounded by various amounts of perivascular adipose tissue (PVAT). While PVAT has been considered a structural support for the vasculature, there is recent evidence that PVAT actively modulates vascular responsiveness by releasing various bioactive molecules. 9 Proinflammatory cytokines and superoxide produced by PVAT promote vasoconstriction in the physiological condition. 10, 11 However, these PVAT-derived factors are also strongly implicated in the pathological processes of vascular dysfunction and extracellular matrix remodeling. 12, 13 Because PVAT is positively correlated with body mass index and waist circumference in several human studies, 14, 15 it is reasonable to speculate that the adverse effect of excess body weight on the vasculature is, at least in part, the result of increased PVAT.
Although the adverse affects of obesity on the vascular system are documented in humans, the pathophysiology that links obesity to aortic stiffening has not been well established. In this study, we hypothesized that obesity and its associated increase in PVAT impair elastic fiber stability, thereby contributing to aortic stiffening. Therefore, we designed experiments to examine the in vivo and in vitro elasticity of the aorta, as well as physical, morphological, and molecular changes in the aorta, in response to obesity.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Higher Aortic PWV and Stiffness in Obese Mice
Two-and 3-month-old obese (ob/ob) mice had significantly higher aortic pulse wave velocities (PWVs) than did control mice ( Figure 1A ), without changes in the heart rate (HR) (data not shown) and blood pressure (BP) ( Table I in the online-only Data Supplement). The pressure-diameter curves showed the attenuated response in the diameter change of the aorta from ob/ob mice ( Figure 1B) , resulting in lower distensibility in ob/ob mice ( Figure 1C ). To directly examine material stiffness, we used atomic force microscopy on the aorta ( Figure 1D ). Obesity shifted the Young's modulus-distribution higher in the aorta (median Young's modulus: 10.1 kPa [kiloPascal] in ob/ob mice versus 6.1 kPa in controls), demonstrating directly that ob/ob aortas were stiffer than control aortas.
Structural Proteins and Maturation Enzyme in the ob/ob Aorta
No evidence of aortic calcification in 3-month-old ob/ob mice was shown by Von Kossa stain (data not shown). Elastin and collagen are the major structural proteins related to aortic stiffness. No difference in the soluble protein levels of tropoelastin or type 1 collagen was observed between ob/ob and control mice (Figure 2A ). ProLOX levels were modestly lower and LOX levels were dramatically lower in ob/ob mice than in controls ( Figure 2B ), which is not accompanied by the change in bone morphogenetic protein-1 (data not shown). Fibulin-4 and -5, known to conduct proper elastogenesis via interaction with LOX, 16, 17 were not altered in the ob/ob aorta. Immunohistochemistry and confocal microscopy showed that the expression of LOX was normal in the adventitia and PVAT of control mice, but attenuated in ob/ob mice ( Figure  2C ). LOX enzyme activity was substantially suppressed in the ob/ob aorta ( Figure 2D ). The aortic content of desmosine, a marker for mature cross-linked elastin, was significantly lower in the aortas of ob/ob mice than of control mice ( Figure  2E ). These results suggest that the protein content and enzyme activity of LOX and the cross-linking of elastin are significantly reduced in the ob/ob aorta. Microscopic examination revealed more breaks in the elastic network of the aortas from ob/ob mice ( Figure 2F and 2G). Elastolytic activity was significantly increased in ob/ob mice ( Figure 2H) . Furthermore, the level of matrix metalloproteinase (MMP)-9, but not MMP-2, was slightly increased in the ob/ob aorta ( Figure 2I ).
PVAT and Aorta Geometry in ob/ob Mice
Dissection revealed the abundant PVAT surrounding the thoracic aorta ( Figure I in the online-only Data Supplement) and abdominal aorta in ob/ob mice. After adjusting for body length, 2-and 3-month-old ob/ob mice had ≈3-4 times more PVAT than did controls. Microscopically, the PVAT in control mice exhibited a brown adipocyte-like feature with multilocular lipid deposits, whereas the PVAT in ob/ob mice exhibited a white adipocyte-like appearance with markedly enlarged lipid droplets with unilocular lipid deposits ( Figure IB in the onlineonly Data Supplement). Despite markedly increased PVAT surrounding the aorta, the media thickness, lumen diameter, lumen and media cross-sectional area and lumen/media ratio were not significantly different between ob/ob and control mice (Table II in Higher Inflammatory Cytokine Expression in the PVAT and Macrophage Infiltrate in the Aortas of ob/ob Mice Proinflammatory cytokines and oxidative stress have been suggested to downregulate LOX and destabilize elastic fibers in the vascular wall. 6, 18 Whereas there were no apparent changes in the expression of chemokines (monocyte chemotactic protein-1, CC Figure 1 . Measures of aortic stiffness in obese (ob/ob) mice. A, Aortic pulse wave velocity (PWV) was measured in 2-and 3-month-old male ob/ob and lean control mice. Mean body weight (BW) during the measurements of PWV is shown. Numbers inside bars= n in each group. B, Pressure-diameter relationship and (C) calculated distensibility in isolated abdominal aorta from ob/ob (n=5) and control (n=8) mice. D, Histograms and corresponding Gaussian distribution curves of Young's modulus measured using atomic force microscopy. Young's modulus measurements were taken on 50 sites of the thoracic aorta from 3-month-old male ob/ob and control mice (2 mice each). *P<0.05 and **P<0.01 compared with control mice. chemokine receptor type 2, and macrophage inflammatory protein-2), adhesion molecules (intercellular adhesion molecule-1 and vascular cell adhesion molecule-1), and cytokines (tumor necrosis factor α and interleukin 6) in the ob/ob aortas, the expression of macrophage markers F4/80 and CD68 were ≈3-4 times higher ( Figure 3A) . Similarly, the upregulation of F4/80 was significant in the ob/ob PVAT ( Figure 3B ). Macrophages were present in the adventitia and PVAT of ob/ob mice, but not in those of control mice ( Figure 3C ). In contrast to that of the aorta, the expression of monocyte chemotactic protein-1, CC chemokine receptor type 2, and tumor necrosis factor α was significantly higher in the ob/ob PVAT. Immunohistochemistry consistently showed significant upregulation of CC chemokine receptor type 2 in the PVAT but not in the aorta of ob/ob mice ( Figure 3D ). These results imply an upregulation of the inflammatory response in the PVAT of ob/ob mice, providing the source of chemokines to recruit macrophages into the microenvironment of the aorta.
Higher Oxidative Stress in the Aortas and PVAT of ob/ob Mice
Expression of the reactive oxygen species-reducing enzymes, catalase and superoxide dismutase 1, was significantly lower in the ob/ob aorta ( Figure 3E ). In contrast, expression of components of nicotinamide adenine dinucleotide phosphate hydrogen oxidase was modestly (p47) and significantly (p67, Cyba, and Cybb) higher in the ob/ob aorta. Catalase and superoxide dismutase 1 expression was significantly lower, and p47, p67, Cyba, and Cybb expression was significantly higher in the ob/ob PVAT ( Figure 3F ). Cells suffering from a superoxide anion attack were clearly abundant in the aortas and PVAT of ob/ob mice ( Figure 3G ). These results suggest increased oxidative stress in the aortas and PVAT of ob/ob mice.
Factors Attenuating LOX Activity
We further examined the factors down-regulating LOX in A7r5 and C3H10T1/2 cells. We found that both tumor necrosis factor α and H 2 O 2 attenuated LOX activity in both cell lines ( Figure  4A and 4B) . We then tested the hypothesis if the factors released from mature adipocyte or PVAT would downregulate LOX. The conditioned medium from differentiated 3T3-L1 adipocytes and the PVAT from ob/ob mice decreased LOX activity in both cell lines ( Figure 4C and 4D) . These results suggest that the factors released from adipocytes or PVAT attenuate LOX activity.
Effect of LOX Inhibition on Aortic Stiffness in Lean and Obese Mice
We next examine the causative role of LOX downregulation in aortic stiffness. We treated wild-type C57BL/6 lean mice with β-aminopropionitrile (BAPN), an inhibitor of LOX. Treatment of BAPN decreased LOX activity in a dose-dependent manner ( Figure 5A ). Administration of BAPN for 9 weeks resulted in significant increases on PWV ( Figure 5B), without changes in the HR and BP (Table III in the online-only Data Supplement). Furthermore, BAPN treatment caused elastin fragmentation ( Figure 5C ) and very mild attenuation in the aortic diameter change ( Figure 5D ) and reduction in distensibility ( Figure  5E ). This was not associated with significant changes in the expression of inflammatory mediators in the aorta ( Figure 5F ). These results suggest that LOX downregulation is sufficient to cause elastin fragmentation and aortic stiffening in wild-type lean mice. Moreover, treatment of BAPN for only 4 weeks significantly increased PWV in ob/ob mice ( Figure 5G and Table IV in the online-only Data Supplement).
Arterial Stiffening and Lower LOX Levels in Obese Humans
Carotid-to-femoral PWV was significantly correlated with body mass index (R=0.288, P=0.004) in relatively healthy human subjects ( Figure 6A ). The correlation remained significant in the multivariate analysis adjusted for age, mean BP, and HR (β=0.266, P=0.040). We then divided our study population into 3 groups using the Asian criteria of the World Health Organization. 19 No differences in age, HR, and mean BP were found between groups (Table V in the online-only Data Supplement). Carotid-to-femoral PWV values in the overweight and obese groups were significantly higher than that in the normal weight group ( Figure 6B ).
To examine the correlation between arterial stiffness and LOX level in humans, another cohort participated in health examination was enrolled. Although no differences in age and HR were found, the mean BP was different between groups (Table VI in the online-only Data Supplement). Two arterial stiffness indices, stiffness index and compliance index, 20, 21 were measured. Obese and overweight subjects showed trends toward higher stiffness index than normal weight subjects ( Figure 6C ). Obese subjects had significantly lower compliance index than those of normal weight and overweight subjects ( Figure 6D ). Serum LOX levels in the obese group were significantly lower than those in the normal weight and overweight groups ( Figure  6E ). While stiffness index is not associated with LOX (β=0.013, P=0.908), compliance index is independently associated with LOX even after adjustments for age, mean BP and HR (β=0.307, P=0.033). These results suggest that obese humans have stiffer aorta and lower serum LOX levels. Although obese subjects showed a dramatic increase in the inflammatory marker high-sensitivity C-reactive protein (Table VI in 
Discussion
Although obesity, usually with comorbidities, has been linked to increased aortic stiffness, 2 the effects of obesity alone, independent of traditional cardiovascular risk factors, on aortic Figure 3 . Expression of inflammatory mediators and reactive oxygen species-related enzymes in the aortas and perivascular adipose tissue (PVAT) of obese (ob/ob) mice. Expression of genes for chemokines, adhesion molecules, macrophage markers, and cytokines in the (A) aortas (n=7 each) and (B) PVAT (n=5-6). mRNA amount is expressed relative to the average expression in control mice. C, Immunofluorescence staining for macrophage marker F4/80 (red) in the thoracic aorta and PVAT. Elastin autofluorescence is shown in green. D, Immunohistochemical staining for CC chemokine receptor type 2 in the thoracic aorta and PVAT. Expression of genes for reactive oxygen species-scavenging enzymes and components of nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) oxidase in the (E) aortas (n=7 each) and (F) PVAT (n=5-6). G, Reactive oxygen species was detected using dihydroethidium staining in the thoracic aorta and PVAT. Cells suffering from a superoxide anion attack are stained bright red. Scale bars are 100 μm in (C) and (G), and 50 μm in (D). *P<0.05, **P<0.01, and ***P<0.001 compared with control mice. All data are resulted from 3-month-old male ob/ob and control mice. stiffness remain unknown. Recently, Rider et al 22 showed that obesity, without other cardiovascular risk factors, is associated with increased aortic stiffness, and that a significant loss of body weight ameliorates aortic stiffening. Thus, obesity alone may be associated with aortic stiffening in humans. In our study, 2 independent cohorts, consisting of subjects without major cardiovascular risk factors, unequivocally showed increases of arterial stiffness indices in obese subjects. Similarly, aortic stiffness has been shown in obese animals. For example, older (7-9 months old) and younger (2.5-3 months old) ob/ob mice, as well as db/db mice, exhibited higher aortic PWVs and lower aortic compliance. [23] [24] [25] In addition, mechanical testing of the aortas from obese Zucker (fa/fa) rats showed greater stiffness in the circumferential and longitudinal directions. 26 However, the mechanistic insight into the link between obesity and aortic stiffening has been lacking.
PWV measurements can be influenced by several factors, such as age, BP, and HR. 27 Although BP and HR were not significantly different in ob/ob and BAPN-treated experiments, a small BP difference could still alter PWV and should be taken into consideration. To directly address material stiffness and elastic properties, namely Young's modulus, atomic force microscopy measurements were taken. Atomic force microscopy has been used to characterize the topographical and mechanical properties of biological samples. 28 This system is particularly advantageous given its ability to measure local elasticity of the low modulus materials down to kPa range. The atomic force microscopy-measured elasticity range of aortas in our study agrees with previous findings of the average of 5-8 kPa in the medial layer of the arterial section. 29 Thus, the increases in PWV and Young's modulus support the notion of greater wall stiffness in the aortas of obese mice.
Increased vascular stiffness has been ascribed to numerous factors, including decreased elastin synthesis, increased collagen content, and altered elastic fiber organization. 30, 31 In the current study, because we analyzed 2 main structural proteins, elastin and collagen, using Western blotting, we did not observe any quantitative changes in their soluble products. Interestingly, we found impairments in the quality of structure proteins, reflected by increased elastic fiber fragmentation, in the aortas of obese mice. Fragmentation of elastic fibers impairs the cushioning effect of the aorta and leads to an increase in aortic stiffness. 32 Elastic fiber fragmentation may result from the defective maturation of elastic fiber formation in the early period of elastogenesis or from increased elastolysis in the later stage. 33 LOX deficiency causes an extended fragmentation of elastic fibers, disruption of vascular smooth muscle cell contact, and breaks of both internal elastic lamina and lamellae. 7, 8 Thus, LOX inhibition can prevent normal formation of desmosine cross-bridges, leading to weakening of the mechanical strength of the aorta. Interestingly, we found that the downregulation of LOX was conspicuous in the adventitia of the aortas and PVAT from obese mice, which was accompanied by fewer desmosine cross-bridges in the aorta. Thus, it is intriguing to speculate that the downregulation of both LOX and normal cross-linking contributes to the fragmentation of the elastic fibers and the reduction of the elastic properties in the aortas of obese mice. In our study, we found serum LOX levels was reduced in obese humans and independently correlated with compliance index. It remains challenging whether serum LOX level is a surrogate of tissue LOX level. However, considering the difficulty in access of human aortic tissues, measurement of serum LOX values in humans would be an alternative. This is supported by studies demonstrating the serum LOX activity and its association with the representative fibrogenesis status within the tissue. 34 Nevertheless, this study is the first demonstration of the potential contribution of LOX downregulation and impaired elastic fiber stability on aortic stiffening in obesity. Our finding regarding LOX is slightly against the view that cross linking increases stiffness, and crosslink breakers reduce stiffness. Arterial effective stiffness and elasticity are attributed by the forces from both elastic and collagenous fibers. Thus, at lower or physiological stress, more load is carried by elastic fibers, whereas at higher stress, collagen become the major mechanical component that carry more of the overall load. 35, 36 Because LOX catalyzes cross-links in both elastin and collagen, the consequence of LOX inhibition can be complicated by alternations in both fibers. The discrepancy on stiffness can be found in several studies. For example, Brüel et al 37 showed that BAPN treatment reduced aortic strength and stiffness, particularly at higher stress, due to reduced collagen cross-links. However, others did not show apparent differences on distensibility after BAPN treatment. 38, 39 In our study, we found prominent elastin fragmentation in BAPN-treated mice, and BAPN treatment increased PWV in both wild-type and ob/ob mice. Importantly, PWV was measured at a condition of physiological pulsatile hemodynamics. However, we only observed very mild attenuation in the pressure-diameter relationship in BAPN-treated mice. It is worth noting that the ex vivo circumferential direction measurement neglects the force-length behavior in the longitudinal direction because arteries are stretched longitudinally in vivo, which is more appropriately applied in PWV measurement. 35 In addition, the effect of reduced elastin cross-linking on effective stiffness is likely masked by reduced collagen cross-linking in the circumferential direction measurement.
Although the elastic fibers last the lifetime of the organism, they are subject to proteolytic degradation and chemical alterations that change their mechanical properties. Thus, qualitative alterations of elastic fibers, such as elastin fragmentation and disorganization, would be more critical in determination of mechanical behavior of the aorta in adult animals. However, in some pathological conditions, elastin expression is increased, but the newly synthesized elastin does not assemble properly. 35 Thus, the reduction of PWV in human studies of 1-year period of weight loss 22, 40 may be attributed to a reduction in elastin fragmentation and an increase in mechanically functional elastic fibers. These are likely caused by the improvement in the hormonal and metabolic environment, which recreates the precise temporal, spatial, and structural interactions necessary for elastic fiber assembly. On the other hand, it is still debatable whether weight loss intervention in a short duration (3-6 months) improves arterial stiffening, because 2 human studies revealed different conclusions. 41, 42 It is questionable whether relatively rapid weight loss prevents fatigue fracture, crosslinking, or degradation of elastin over weeks. Thus, the reduction of arterial stiffness in a relatively short time frame may be attributed to changes in local, humoral, or neural modulation of smooth muscle tone. For example, improved nitric oxide bioavailability, reductions in angiotensin II, and reductions in sympathetic neural activity may contribute to the favorable changes in arterial stiffness observed with short-term weight loss.
Elastic fiber fragmentation may also result from an upregulation of elastase activity in association with an increased susceptibility to elastolysis of the elastic fiber formed. 43 A loss of proper organization and arrangement of the elastic fiber network attributable to elastolysis impairs aortic wall elastic properties and structural integrity. Inflammation and macrophage infiltration of the aortic wall have been shown to induce activation of MMPs and increase elastolysis. 44 In addition, LOX inhibition renders the presence of soluble forms of extracellular matrix proteins and increases their susceptibility to degradation by proteinases. 45 Our data showed that aortic lysate from obese mice had increased elastolytic activity, which is accompanied by modestly increased aortic MMP-9 and significantly increased circulating MMP-9 levels (data not shown). However, the role of MMPs on arterial stiffness is controversial. While a human study reported positive association between aortic stiffness and serum levels of MMP-9, 46 another study showed negative association. 47 Thus, a direct measurement of the level or activity of MMPs in the aorta may be better to determine the local tissue elastase activity.
Obesity is accompanied by low-grade inflammation. Although macrophage infiltration was found in the ob/ob aorta, reflected by increased expression and staining of macrophage markers, we found no apparent changes in the expression of cytokines or chemokines in the ob/ob aorta. Interestingly, the increased expression of cytokines and chemokines were prominent in the PVAT physically attached to the adventitia. These chemokines may recruit immune cells into PVAT through the vasa vasorum of the adventitia. These findings suggest that proinflammatory and hypertrophied PVAT is important in mediating the vascular inflammatory response in obesity.
In summary, our results demonstrated that obesity resulted in aortic stiffening in both humans and mice. Both destabilized elastic fiber networks and increased elastolytic activity in the aortas of obese mice contributed to aortic stiffening. The downregulation of LOX in wild-type lean mice caused elastin fragmentation and induced a significant increase in PWV. Proinflammatory and pro-oxidative PVAT surrounding the aorta provide an explanation for LOX attenuation in the aortas of obese mice. Moreover, obese humans have stiffer arteries and lower serum LOX levels. Thus, our study highlights the importance of the clinical observation of aortic stiffening in obesity. More important, our study points out potential avenues for exploration of PVAT, LOX, and elastic fiber crosslinking that could illuminate the mechanism behind this clinical observation.
Significance
Our results demonstrated that obesity resulted in aortic stiffening in both humans and mice, and established a causal relationship between lysyl oxidase downregulation and aortic stiffening. This study highlights lysyl oxidase downregulation and proinflammatory, pro-oxidative perivascular adipose tissue as key mediators of aortic stiffening in obesity, and emphasizes potential contribution of lysyl oxidase downregulation and impaired elastic fiber stability on obesity-induced aortic stiffening. Thus, our study underscores the clinical observation of aortic stiffening in obesity, and points out potential avenues for exploration of perivascular adipose tissue, lysyl oxidase activity, and elastic fiber crosslinking that could illuminate the mechanism behind this clinical observation. Finally, understanding these processes has several clinical implications, including the interpretation and development of therapeutic strategies for aortic stiffening in obesity. Because increased stiffness may be detected in the early stage of obesity, more aggressive treatments and monitoring procedures should be instituted for patients at a higher risk for developing accelerated vascular stiffness.
